Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cellebrite to Report Fourth-Quarter and Fiscal Year 2024 Financial Results on February 13, 2025
-
Veritex Holdings, Inc. Announces Dates of Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
-
MIND CTI to Acquire Aurenz GmbH
-
Westwood Announces Monthly Income Distributions for Westwood Salient Enhanced Midstream Income ETF (MDST) and Westwood Salient Enhanced Energy Income ETF (WEEI)
-
Evaxion announces extension to January 14, 2025, of plan to implement ADS ratio change
-
Michelin : Disclosure of the total number of voting rights and of the number of shares making up the Company’s capital
-
NEXTGEN DIGITAL ANNOUNCES $1.0 MILLION NON-BROKERED PRIVATE PLACEMENT FINANCING
-
Jeffs’ Brands Presents Estimated Year over Year Growth, Targets $20 million Revenue in 2025, Anticipates over 120% Revenue Growth since its IPO in 2022
-
Swipe-to-Earn Revolution: PAWS Goes Live on XT.COM
-
Enrolled Agents Are Taxpayers' Go-To Resource for Tax Season
-
Enrolled Agents Are Taxpayers' Go-To Resource for Tax Season
-
Notification of major shareholding
-
Y-mAbs Appoints Experienced Commercial Leader as Head of DANYELZA Business Unit
-
Constellation Brands Reports Third Quarter Fiscal 2025 Financial Results
-
CNB Financial Corporation and ESSA Bancorp, Inc. Announce Strategic Merger
-
Golconda Gold Ltd. Announces Appointment of Vikram Kapoor to Board and Equity Grants
-
Tourmaline Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. Ridker
-
Churchill Downs Incorporated 2024 Fourth Quarter and Full Year Financial Results Conference Call Invitation
-
Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference
-
ZenaTech’s ZenaDrone Multipurpose AI Drone Applies for FAA Part 137 Crop Sprayer Certification for Agricultural and Wildfire Industry Use
-
Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery
-
Ranchero Completes Debt Settlement Transaction
-
Prairie Operating Co. Completes Shelduck South Pad, Prepares for New Developments
-
Royalty Pharma Announces Transformative Step in Company’s Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program
-
Rhythm Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2024 Net Product Revenues, Pipeline Advancements and Upcoming Milestones
-
Alliance Witan PLC - Net Asset Value
-
Revolutionizing Psychology: Asian Conference on Applied Psychology 2025 Unveils VR Networking and Global Collaboration
-
Y-mAbs Provides Strategic Business Update and 2025 Priorities
-
HBT Financial, Inc. to Announce Fourth Quarter 2024 Financial Results on January 22, 2025
-
G2 Names INE 2025 Networking and Cybersecurity Training Leader
-
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Dominant SARS-CoV-2 Variant XEC
-
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Dominant SARS-CoV-2 Variant XEC
-
Tilray Brands Reports Q2 2025 Financial Results
-
Belharra Therapeutics Announces Appointment of Sean Buchanan, Ph.D., as Chief Scientific Officer and Retirement of Gary O’Neill, Ph.D.
-
BioCryst Announces Preliminary Full Year 2024 ORLADEYO® (berotralstat) Net Revenue of $437 Million (+34 percent y-o-y)
-
Arvinas Updates Guidance for First- and Second-Line Phase 3 Combination Trials with Vepdegestrant, Highlights Upcoming Milestones, and Provides Corporate Update
-
GH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents
-
Nickel Sulphate Futures Now Live for Trading on Abaxx Exchange
-
Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes
-
Bio-Path Holdings Provides 2025 Clinical and Operational Update
-
Lantronix Names Brent Stringham as CFO
-
Plymouth Industrial REIT Provides Activity Update for Fourth Quarter 2024
-
Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2025
-
U.S. Energy Corp. Announces Recent AcquisitionTargeting Industrial Gas Production
-
Gencor Announces Receipt of NYSE Regulation Notice Regarding Late Filing of the Annual Report on Form 10-K for the Year Ended September 30, 2024
-
The “Hottest” Bagel in New York is Opening Its First Boston Location
-
Walden Biosciences Highlights 2024 Accomplishments and 2025 Priorities
-
atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health
-
Green Thumb Industries Announces First-Of-Its-Kind Partnership with Iconic Chicago Music Venue, The Salt Shed, Introducing Retail Store RISE at Salt Shed and RYTHM Brand Activations
-
Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)
